Increase in admissions related to giant cell arteritis and polymyalgia rheumatica in the UK, 2002-13, without a decrease in associated sight loss: potential implications for service provision-Reference-Cited by-同舟云学术

Increase in admissions related to giant cell arteritis and polymyalgia rheumatica in the UK, 2002-13, without a decrease in associated sight loss: potential implications for service provision

Published:2014-11-19 Issue:2 Volume:54 Page:375-377
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Mollan S. P.,Begaj I.,Mackie S.,O'Sullivan E. P.,Denniston A. K.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/54/2/375/6898247/keu433.pdf

Reference3 articles.

1. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001

2. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica

3. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort Study;Doklady Biochemistry and Biophysics;2024-07-13

2. Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Polymyalgia Rheumatica Presenting with Double Vision;Neuro-Ophthalmology;2024-06-17

3. Cranial involvement in giant cell arteritis;The Lancet Rheumatology;2024-06

4. Clinical manifestations and prognosis of giant cell arteritis: A retrospective cohort study;Rheumatology Science and Practice;2023-12-31

5. The first giant cell arteritis hospital quality standards (GHOST);Eye;2023-06-21